EUVIMEDObjevte EUVIMED
Open access

Targeting Cathepsin K to Accelerate Diabetic Wound Healing

Anne Chenchar, Vitoria Mattos Pereira, Anisha Apte, Bailey D Lyttle, Alyssa E Vaughn, Tanner Lehmann, James R Bardill iD, Carlos Zgheib, Kenneth W Liechty, Kelly C S Roballo, Zhaojie Zhang, Brenda M Alexander and 1 more

ACS Pharmacology & Translational Science · 2025-07-11 · 8 (7) · 2258-2269

DOI: 10.1021/acsptsci.5c00295 ↗

At a glance

Journal article in ACS Pharmacology & Translational Science, published online on 2025-06-20. Written by Anne Chenchar and 12 co-authors. Institution: School of Pharmacy, Biomedical Sciences Graduate Program, Department of Zoology and Physiology, Department of Animal Sciences, University of Wyoming,…. Cited 7 times so far (Crossref); 45 references. The full text is freely available in PubMed Central. Funded by: NIGMS NIH HHS, NIDDK NIH HHS, National Institute of Diabetes and Digestive and Kidney Diseases.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Objective

Elevated protease activity impairs wound healing. Cathepsin K is a cysteine protease with potent collagenolytic and elastolytic activity. This study examined the effects of odanacatib, a cathepsin K inhibitor, on wound healing in a diabetic porcine model. Additionally, it assessed whether the genetic deletion of cathepsin K improves wound healing in diabetic mice. Approach: Three cohorts of three-month-old female Yorkshire pigs (eight to ten pigs per cohort) were rendered diabetic via intravenous injections of streptozotocin (STZ, 75 mg/kg). After 4 weeks, ten full-thickness (∼300 μm) excisional skin wounds, each measuring one square inch, were created on the dorsal surface of each animal. The wounds were treated with either vehicle or odanacatib (30 or 300 ng/mm2) via intradermal injection on days 0, 3, 7, and 14. For mouse studies, diabetes was induced in cathepsin K knockout (Ctsk -/- ) and wild-type C57BL/6 mice via STZ injections, and a single full-thickness excisional wound was created on each mouse. The wounds were photographed and assessed on days 0, 7, 14, 21, and daily until complete closure. Wound healing progression was evaluated by measuring wound closure rates, CD31 expression, and histology. An in vitro scratch assay was utilized to assess the effect of odanacatib on the migration of cultured skin fibroblasts and keratinocytes under high-glucose conditions.

Results

Odanacatib treatment significantly accelerated wound closure in diabetic pigs, promoting epithelialization and ECM stability. Similarly, diabetic Ctsk-/- mice exhibited improved healing compared to wild-type controls. In vitro, odanacatib increased the migration of fibroblasts and keratinocytes under hyperglycemic conditions. Innovation and Conclusion: This study is the first to demonstrate that inhibiting cathepsin K, either genetically or pharmacologically, improves diabetic wound healing. These findings position cathepsin K as a promising therapeutic target for the treatment of chronic wounds.

Subjects

Author keywords

cathepsin Kdiabetesmouse modelodanacatibporcine modelwound healing

Authors and institutions

  • School of Pharmacy, Biomedical Sciences Graduate Program, Department of Zoology and Physiology, Department of Animal Sciences, University of Wyoming, 1000 E. University Avenue, Laramie, Wyoming 82071, United States.
  • Laboratory for Fetal and Regenerative Biology, Department of Surgery, College of Medicine, University of Arizona, 1656 E Mabel Street, Tucson, Arizona 85721, United States.
  • Laboratory for Fetal and Regenerative Biology, Department of Surgery, University of Colorado Denver, Anschutz Medical Campus and Children's Hospital Colorado, 12631 East 17th Avenue, Aurora, Colorado 80045, United State…
  • Nutriwyo LLC, 1938 Harney Street, Suite 210, Laramie, Wyoming 82072, United States.

ORCID profiles: James R Bardill, Sreejayan Nair

Funding

  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • National Institute of Diabetes and Digestive and Kidney Diseases
  • National Institute of General Medical Sciences

Cite

APA

Chenchar, A., Mattos Pereira, V., Apte, A., Lyttle, B. D., Vaughn, A. E., Lehmann, T., Bardill, J. R., Zgheib, C., Liechty, K. W., Roballo, K. C. S., Zhang, Z., Alexander, B. M., & Nair, S. (2025). Targeting Cathepsin K to Accelerate Diabetic Wound Healing. ACS Pharmacology & Translational Science, 8(7), 2258-2269. https://doi.org/10.1021/acsptsci.5c00295

Vancouver

Chenchar A, Mattos Pereira V, Apte A, Lyttle BD, Vaughn AE, Lehmann T, et al. Targeting Cathepsin K to Accelerate Diabetic Wound Healing. ACS Pharmacology & Translational Science. 2025;8(7):2258-2269. doi:10.1021/acsptsci.5c00295

BibTeX
@article{Chenchar2025,
  author = {Chenchar, Anne and Mattos Pereira, Vitoria and Apte, Anisha and Lyttle, Bailey D and Vaughn, Alyssa E and Lehmann, Tanner and Bardill, James R and Zgheib, Carlos and Liechty, Kenneth W and Roballo, Kelly C S and Zhang, Zhaojie and Alexander, Brenda M and Nair, Sreejayan},
  title = {Targeting Cathepsin K to Accelerate Diabetic Wound Healing},
  journal = {ACS Pharmacology & Translational Science},
  year = {2025},
  volume = {8},
  number = {7},
  pages = {2258--2269},
  doi = {10.1021/acsptsci.5c00295}
}
Start for free →